Cargando…
New Approaches for Cancer Treatment: Antitumor Drugs Based on Gene-Targeted Nucleic Acids
Currently, the main way to fight cancer is still chemotherapy. This method of treatment is at the height of its capacity, so, setting aside the need for further improvements in traditional treatments for neoplasia, it is vital to develop now approaches toward treating malignant tumors. This paper re...
Autores principales: | Patutina, O.A., Mironova, N.L., Vlassov, V.V., Zenkova, M.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
A.I. Gordeyev
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3347510/ https://www.ncbi.nlm.nih.gov/pubmed/22649602 |
Ejemplares similares
-
Tumoricidal Activity of RNase A and DNase I
por: Patutina, O.A., et al.
Publicado: (2010) -
Dual miRNases for Triple Incision of miRNA Target: Design Concept and Catalytic Performance
por: Patutina, Olga, et al.
Publicado: (2020) -
Peptide-oligonucleotide conjugates exhibiting pyrimidine-X cleavage specificity efficiently silence miRNA target acting synergistically with RNase H
por: Patutina, O. A., et al.
Publicado: (2018) -
MicroRNA Drop in the Bloodstream and MicroRNA Boost in the Tumour Caused by Treatment with Ribonuclease A Leads to an Attenuation of Tumour Malignancy
por: Mironova, Nadezhda, et al.
Publicado: (2013) -
The systemic tumor response to RNase A treatment affects the expression of genes involved in maintaining cell malignancy
por: Mironova, Nadezhda, et al.
Publicado: (2017)